A

Over the past six months (April 2026 - October 2026), Agilent Technologies (A) experienced several notable stock events. The Q3 2026 Earnings Report on August 26, 2026, showed strong financial results with revenue of $1.88 billion, an 8.1% increase, and expanded GAAP operating margin, leading the company to raise its fiscal year 2026 guidance. Between September and October 2026, Agilent introduced several new products, including the NovoStation Sample Preparation System, Gen5 AI Cell Identification Module, and TapeStationDx Systems, indicating ongoing innovation. In October 2026, BofA raised its price target on Agilent (A) to $190 from $180, maintaining a Buy rating. The stock has shown strong performance, increasing 17.43% over the last month and 21.57% over the last year as of early October 2026, with the share price reaching $156.47 as of September 18, 2026.